Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali Ҷилди 6 № 2 (2025)
MODIFICATION OF ANTI-GLYCEROUS THERAPY AS A FACTOR IN IMPROVING THE QUALITY OF LIFE IN ELDERLY PATIENTS WITH TYPE 2 DIABETES
Норматов Муроджон Бурибоевич, Хайдаров Санжар Низамитдиниович
Аннотатсия
Relevance. Type 2 diabetes mellitus (T2DM) is widespread among elderly people and causes serious macro- and microvascular complications. A characteristic feature of T2DM in elderly patients is an increased risk of developing geriatric syndromes and hypoglycemic conditions, which leads to a significant decrease in their quality of life. The aim of our study was to examine the quality of life of elderly patients with type 2 diabetes mellitus and the impact of glucose-lowering therapy on it. Materials and methods. We conducted a prospective randomized study involving 2 groups of elderly women. The first group consisted of 40 patients with T2DM (mean age 68.25 ± 4.12 years) receiving traditional glucose-lowering therapy. The second group consisted of 40 patients with T2DM (mean age 68.35 ± 3.89 years) treated with our developed method: diet #9, intravenous gliclazide, metformin, sublet, cholecalciferol drops (loading dose for a month, then maintenance dose), and physical activity. Elderly patients with T2DM experience a decrease in health-related quality of life. Conclusions: Modification of glucose-lowering therapy by adding cholecalciferol and metformin to the usual treatment regimen contributed to improving the quality of life in this category of patients. This treatment method is safe, has a low risk of hypoglycemia, and helps reduce patients' body weight.
сахарный диабет 2 типа, качество жизни, гипогликемия, холикальциферол, метформинtype 2 diabetes mellitus, quality of life, hypoglycemia, cholecalciferol, metformin2-tip qandli diabet, hayot sifati, gipoglikemiya, xolekalsiferol, metformin
Манбаи метамаълумот: бойгонии OAI-PMH-и маҷалла · Sindex матни пурраро нигоҳ намедорад, ба манбаъ пайванд медиҳад.